
Semaglutide is a synthetic peptide analog of the incretin hormone glucagon-like peptide-1 (GLP-1) investigated in experimental and clinical research as a regulator of metabolic signaling and endocrine pathways associated with glucose homeostasis and energy balance. Structural modifications incorporated into the peptide enhance enzymatic stability and extend circulating half-life, allowing researchers to study prolonged GLP-1 receptor activation under controlled experimental conditions.


Videos by independent creators on YouTube. BioVantix doesn't make or endorse them, and they aren't usage instructions. They load from YouTube only when you play them.